Malignant salivary gland tumors make up a small proportion of malignancies worldwide, yet
vary widely in terms of histology, patterns of spread, and recurrence. A better understanding …

Background Salivary duct carcinoma (SDC) and adenocarcinoma, not otherwise specified
(adeno‐NOS), are rare salivary gland cancers. Data on the efficacy of systemic therapy for …

Salivary gland carcinomas (SGCs) are the most heterogeneous subgroup of head and neck
malignant tumors, accounting for more than 20 subtypes. The median age of SGC diagnosis …

Mucoepidermoid carcinoma (MEC) is the most frequent malignant salivary gland cancer.
Response to chemoradiotherapy is modest, and therefore radical surgery remains the …

Background The optimal treatment for pulmonary mucoepidermoid carcinoma (MEC), a rare
type of tumor, has not been established yet. This study analyzed the survival of pulmonary …

Salivary gland cancers represent a rare group of tumors composed by over 20 histological
subtypes. Initially treated as one single disease, its diagnosis, prognosis, and treatment are …

Laryngeal cancer (LC) remains a challenging disease to treat. The majority of LCs
diagnosed worldwide are squamous cell carcinomas (SCC), and current treatment …

Objectives: Adjuvant radiation therapy (RT) is indicated for patients with salivary gland
malignancies with risk factors for recurrence following resection. We analyzed patients …

BACKGROUND: Primary adenocarcinomas of the parotid gland are rare and account for
less than 5% of all head and neck malignant neoplasms. There is considerable variation in …

Systemic therapies for salivary gland carcinomas: an overview of published clinical trials -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …